Period Ending |
Dec 31, 2014 |
Sep 30, 2014 |
Jun 30, 2014 |
Mar 31, 2014 |
Total Revenue |
29 |
11 |
– |
– |
Cost of Revenue |
9 |
3 |
– |
– |
|
Gross Profit |
20 |
8 |
– |
– |
|
|
Operating Expenses |
|
Research Development |
– |
– |
– |
– |
|
Selling General and Administrative |
717 |
1,054 |
1,793 |
1,681 |
|
Non Recurring |
– |
– |
– |
1,356 |
|
Others |
30 |
30 |
30 |
63 |
|
|
|
Total Operating Expenses |
– |
– |
– |
– |
|
|
Operating Income or Loss |
(728) |
(1,535) |
(1,365) |
(3,101) |
|
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
(600) |
(712) |
343 |
(1,845) |
|
Earnings Before Interest And Taxes |
(1,327) |
(1,788) |
(1,480) |
(4,946) |
|
Interest Expense |
58 |
31 |
95 |
276 |
|
Income Before Tax |
(1,385) |
(1,820) |
(1,576) |
(5,221) |
|
Income Tax Expense |
– |
– |
– |
– |
|
Minority Interest |
– |
– |
– |
– |
|
|
|
Net Income From Continuing Ops |
(1,385) |
(1,820) |
(1,576) |
(5,221) |
|
|
Non-recurring Events |
|
Discontinued Operations |
– |
– |
– |
– |
|
Extraordinary Items |
– |
– |
– |
– |
|
Effect Of Accounting Changes |
– |
– |
– |
– |
|
Other Items |
– |
– |
– |
– |
|
|
Net Income |
(1,385) |
(1,820) |
(1,576) |
(5,221) |
Preferred Stock And Other Adjustments |
– |
– |
– |
– |
|
Net Income Applicable To Common Shares |
(1,385) |
(1,820) |
(1,576) |
(5,221) |
|